Semaglutide is a viable option for individuals with a BMI of 30 or higher, or 27 and higher with a weight-related health condition like diabetes or high blood pressure
A physical exam will follow, where the provider may check the patients balance, eye movements, and hearing
Randomized to retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg weekly, or placebo, for 48 weeks
Pairing compounded semaglutide with the optional Precision Peptide Genetic Test ($99 add-on after first month) allows your provider to personalize your protocol based on your unique peptide pathways, potentially unlocking better monthly weight loss outcomes than a generic approach
[DOI] [PMC free article] [PubMed] [Google Scholar] 116.Moulton C.D., Rokakis A.S., Pickup J.C., Young A.H., Stahl D., Ismail K
Place in therapy Spinal muscular atrophy (SMA) is a rare, debilitating, hereditary disease characterized by progressive motor function decline and muscular atrophy that spares cognitive abilities